SU1436882A3 - Method of producing diphenylmethyl ether of 7-benzylidene-amino-3-(3-chloro-1-propen-1-yl) - cephem-4-carboxylic acid - Google Patents
Method of producing diphenylmethyl ether of 7-benzylidene-amino-3-(3-chloro-1-propen-1-yl) - cephem-4-carboxylic acid Download PDFInfo
- Publication number
- SU1436882A3 SU1436882A3 SU864020682A SU4020682A SU1436882A3 SU 1436882 A3 SU1436882 A3 SU 1436882A3 SU 864020682 A SU864020682 A SU 864020682A SU 4020682 A SU4020682 A SU 4020682A SU 1436882 A3 SU1436882 A3 SU 1436882A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- cephem
- carboxylic acid
- formula
- amino
- propen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/78—Separation; Purification; Stabilisation; Use of additives
- C07C45/79—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Description
0000
0000
ы s
Изобретение относитс к способу получени нового химического соединени , а именно дифекилметилового эфира 7-бензилиденамино-3-(3-Х1тор- -пропей- 1-ил)-З-цефем-4-карбоновой кисло ты, вл ющегос полупродуктом в синтезе новых антибиотиков цефалоспори- нового р да.This invention relates to a process for the preparation of a new chemical compound, namely, 7-benzylideneamino-3- (3-H1-3-propy-1-yl) 3-cephem-4-carboxylic acid diphekylmethyl ester, which is an intermediate in the synthesis of new cephalosporic antibiotics. - new p yes.
Целью изобретени вл етс получение нового полупродукта дл синте- за цефалоспориновых антибиотиков против ю-таммов микроорганизмов, устойчивых к известным антибиотикам пени- циллинового и цефалоспоринового р дов .The aim of the invention is to obtain a new intermediate for the synthesis of cephalosporin antibiotics against microorganisms resistant to the known antibiotics of the penicillin and cephalosporin series.
П р и м е р Ч. Получение дифенил- метил-7-бензилиденамино-З- f (трифе- ннлфосфоранилиден) метил 3-цефем- 4 карбоксилата.EXAMPLE CHP. Preparation of diphenylmethyl-7-benzylideneamino-3-f (triphenylphosphoranylidene) methyl 3-cephem-4 carboxylate.
А. хлорида дифенилме- тил 7-бенз1-тиденамино-3--трифенилфос- фониометил-3-цефем-А-карб.оксилата „A. Diphenylmethyl chloride 7-benz1-thienamino-3-triphenylphosphonomethyl-3-cephem-A-carboxyoxylate
К суспензии дифенилметил 7-ами-. но-З-хлорметил-З-цефем-4-карбоксила- та гидрохлорида (II гидрохлорид) (200 г, 0,44 моль) в метиленхлориде (940 мл)добавл ют 1н. гид;9Оокись натри (440 мл) при комнатной темпера- тзфе. Смесь- встр хивают в течение 10 мин и органический слой отдел ют . К органическому слою добавл ют сульфат магни (75 г) и бензальдегид (51 г, 0,48 моль) и смеси дают возмо ность сто ть в течение 3 ч, Реакцион HjTO смесь фильтруют и нерастворимые вещества промьшают метиленхлоридом (200 мл) . К объединенному фильтрату промьшным водам добавл ют трифенил- фосфин (126 г, 0,48 моль). Смесь кон центрируют до примерно 400 мл и оставл ют , сто ть в течение 4 дней. Получающеес в зкое масло разбавл ют этилацетатом (1 л) и растирают дл отделени целевого соединени в виде бледно-желтого кристаллического порошса, которьй собирают с помощью фильтровани и .сушат в вакууме. Выход 322 г (96%) . Температура плавлени 185-190 0 (разл.)To suspension diphenylmethyl 7-ami. but-3-chloromethyl-3-cephem-4-carboxylate hydrochloride (II hydrochloride) (200 g, 0.44 mol) in methylene chloride (940 ml) was added 1N. guide; sodium oxide (440 ml) at room temperature. The mixture is shaken for 10 minutes and the organic layer is separated. Magnesium sulfate (75 g) and benzaldehyde (51 g, 0.48 mol) are added to the organic layer and the mixture is allowed to stand for 3 hours. The reaction of the HjTO mixture is filtered and insoluble substances are washed with methylene chloride (200 ml). Triphenylphosphine (126 g, 0.48 mol) is added to the combined filtrate with industrial water. The mixture is concentrated to about 400 ml and left to stand for 4 days. The resulting viscous oil is diluted with ethyl acetate (1 L) and triturated to separate the desired compound as a pale yellow crystalline powder, which is collected by filtration and dried in vacuo. Yield 322 g (96%). Melting point 185-190 ° (decomp.)
ИК-спектр: (, (КВг), 1780; .1720; 1630.IR spectrum: (, (KBG), 1780; .1720; 1630.
УФ-спектр: д д (метиленхлорид), им (6): 260 (24100).UV spectrum: d d (methylene chloride), them (6): 260 (24100).
Б. Получение дифенилметил 7-бен- -зш1иденамино-3- Хтрифенилфосфорани- лиден) метил -З-цефем-4-карбоксйлата.B. Preparation of diphenylmethyl 7-benz-3a-1-amino-3-Htriphenylphosphoranilidene-methyl-3-cephem-4-carboxylate.
Смесь подукта со стадии А (322 г, 0,42 моль) и 5 и. карбоната натри A mixture of the product from stage A (322 g, 0.42 mol) and 5 and. sodium carbonate
00
5five
00
5 Q 5 Q
00
5five
5five
00
(252 мл) в етиленхлориде (1,6 л) перемешивают энергично в течение 15 мин при комнатной температуре. Органический слой отдел ют, сушат над сульфатом магни и концентрируют примерно до 500 мл объема. Концентрат добавл ют к ацетону (1 л) при перемешивании , получа светло-желтый кристаллический порошок, который собирают с помощью фильтровани с выходом 237 г (78%) целевого соединени , плав щегос при 195-198 С (разл.)(252 ml) in ethylene chloride (1.6 l) is stirred vigorously for 15 minutes at room temperature. The organic layer is separated, dried over magnesium sulfate, and concentrated to approximately 500 ml volume. The concentrate is added to acetone (1 L) with stirring to give a light yellow crystalline powder, which is collected by filtration to yield 237 g (78%) of the title compound, melting at 195-198 ° C (decomp.)
ИК-спектр: д с(КВг), :1770, 1620.IR spectrum: d s (KBG),: 1770, 1620.
УФ-спектр: А„акс (метиленхлорид), ;нм (П: 254 (23000); 389 (22000).UV spectrum: А „aks (methylene chloride),; nm (P: 254 (23000); 389 (22000).
ЯМР-спектр 5 (CDClj) млн.д:2,56 и 3,1б (2H,ABg), 5,00; (IH,дублет, J 4 Гц)5 5,23 (1Н, дублет, J 4 Гц); 5,47 (1Н,дублет I 22 Гц); 6,95 (1Ы, синглет); 7,2-7,8 (ЗОН, мультиплет), 8,55 (1Ы, синглет).NMR spectrum 5 (CDCl1) ppm: 2.56 and 3.1b (2H, ABg), 5.00; (IH, doublet, J 4 Hz) 5 5.23 (1H, doublet, J 4 Hz); 5.47 (1H, doublet, I 22 Hz); 6.95 (1Y, singlet); 7.2-7.8 (ZONE, multiplet), 8.55 (1Y, singlet).
В. Получение дифенилметил 7-бен- зилиденамино-3(трифенилфосфоранили- ден)метил3-3-цефем-4 карбоксилата.B. Preparation of diphenylmethyl 7-benzylideneamino-3 (triphenylphosphoranylidene) methyl 3-3 cephem-4 carboxylate.
К раствору йодистого дифенилметил 7-бенз1-шиданамин6-3-(три- фенилфосфонио)метш13-3-цефем-4-кар- , боксилата (60 г, 70 ммоль) в метиленхлориде (350 мл) добавл ют гидроокись натри (140 мл) и Амберлит lRA-410 (ОН форма, 35 г) при 5°С. Смесь перемешивают в течение 1 ч при и фильтруют. Органический слой от- отдел ют, сушат над сульфатом магни , концентрируют приблизительно до . 100 мл объема и осаждают этилацетатом (500 мл). Получающеес желтое твердое вещество собирают с помощью фильтровани и сушат в вакууме, получа 48 г (94%) целевого соединени , плав щегос при 195-8 С (разложение).To a solution of diphenylmethyl iodide 7-benz1-shidanamine6-3- (triphenylphosphonio) metsh13-3-cephem-4-car-, bauxilate (60 g, 70 mmol) in methylene chloride (350 ml) is added sodium hydroxide (140 ml) and Amberlite lRA-410 (OH form, 35 g) at 5 ° C. The mixture is stirred for 1 hour and filtered. The organic layer is separated, dried over magnesium sulfate, concentrated to approximately. 100 ml of volume and precipitated with ethyl acetate (500 ml). The resulting yellow solid was collected by filtration and dried in vacuo to give 48 g (94%) of the title compound, melting at 195-8 ° C (decomposition).
ИК-спектр (КБг), 1770, 1620.IR spectrum (KBg), 1770, 1620.
П р и м е р 2. Получение дифенилметил 7-бензилиденамино-3-(3-хлор-1- пропен-1-ил)-З-цефем-4-карбоксилата.PRI mme R 2. Preparation of diphenylmethyl 7-benzylidene-amino-3- (3-chloro-1-propen-1-yl) -3-cephem-4-carboxylate.
К перемешиваемому раствору целевого соединени примера 1Б или 1В (2,9 г, 4 ммоль) в смеси метиленхлори- да (40 мл) и ВОДЬ (10 мл) добавл ют безводный хлорацетальдегид (800 мг) при комнатной температуре. К смеси , добавл ют дополнительно 800 мг хлор- ацетальдегида трем порци ми на прот жении периода в 1 ч, при этом рН смеси поддерживают между 6 и 9 путем добавлени 1 н. гидроокиси натри .To a stirred solution of the title compound of Example 1B or 1B (2.9 g, 4 mmol) in a mixture of methylene chloride (40 ml) and WATER (10 ml) was added anhydrous chloroacetaldehyde (800 mg) at room temperature. To the mixture, an additional 800 mg of chloroacetaldehyde is added in three portions over a period of 1 hour, while the pH of the mixture is maintained between 6 and 9 by the addition of 1N. sodium hydroxide.
Спуст 15 мин водный слой удал ют, а органический слой сушат над сульфатом магни . Упаривание растворител дает красное масло, которое раствор - ют в смеси этилацетата и изопропило- вого эфира (1/2, 80 мл). Раствор про- мьшают последовательно насьщенным водным бикарбонатом натри (10 мл) и водой (10 мл). После сушки над сульфа- том магни удаление растворител дает 3,3 г желтого масла. Раствор масла в матиленхлориде (50 мл) фильтруют с помощью сидикагел (12 г, Ва- когель С-200),содержащего 1/1,5 М фосфатный буфер (1,2 мл, рН 6,4) и силикагель промывают метиленхлоридом (so мл) фильтрат и промывную воду объедин ют и упаривают досуха. Остаток растирают с к гексаном, получа 1,7 г (80%) целевого соединени в |Виде желтого порошка. Спектр-ЯМР показал , что хлорпропенильна часть молекулы имеет конфигурацию. Температура плавлени выше 50 С (разлож.) ИК-спектр,о,кс(КВг),см- : 3400} 1775; 1720; 1630.After 15 minutes, the aqueous layer was removed and the organic layer was dried over magnesium sulfate. Evaporation of the solvent gave a red oil, which was dissolved in a mixture of ethyl acetate and isopropyl ether (1/2, 80 ml). The solution is washed in succession with a saturated aqueous sodium bicarbonate (10 ml) and water (10 ml). After drying over magnesium sulphate, removal of the solvent gives 3.3 g of a yellow oil. The oil solution in matylene chloride (50 ml) is filtered using cedicagel (12 g, W-cogel C-200) containing 1 / 1.5 M phosphate buffer (1.2 ml, pH 6.4) and the silica gel is washed with methylene chloride (so ml) the filtrate and the wash water are combined and evaporated to dryness. The residue was triturated with hexane to give 1.7 g (80%) of the title compound in the form of a yellow powder. The NMR spectrum showed that the chloropropenyl part of the molecule has a configuration. Melting point above 50 ° C (decomposition). IR spectrum, o, kc (KBr), cm-: 3400} 1775; 1720; 1630.
УФ-спекгр /.(этагюп ) ,км (5): 253(11000); 258(11000); 265(10000); 273(8300); 281(7000),290(6300).UV spectrum /. (Etagüp), km (5): 253 (11000); 258 (11,000); 265 (10,000); 273 (8300); 281 (7000), 290 (6300).
ЯМР-спектр (DMCO-dfe), млн.д: 3,63 (2Г,шир.синглет.2-Н);4,0 (2Н, мультиплет, СН,г.-С1); 5,42 (2Н, мультиплет 6Н и ); 5,72 (1Н,дублет J 4,5, 7-Н); 6,27 (Ш, дублет, J 11,3-СН); 6,85 (Ш, синглет, CHPh)i 7,33 (ЮН, мультиплет , Ph2-H).NMR spectrum (DMSO-dfe), ppm: 3.63 (2G, s-sinlet.2-H); 4.0 (2H, multiplet, CH, g-C1); 5.42 (2H, multiplet 6H and); 5.72 (1H, doublet J 4.5, 7-H); 6.27 (W, doublet, J 11.3-CH); 6.85 (W, singlet, CHPh) i 7.33 (YUN, multiplet, Ph2-H).
Приготовление безводного хлор- ацетальдегида.Preparation of anhydrous chloroacetaldehyde.
Бозводный хлористый кальций добавл ют к охлажденному раствору 50%-ного водного хлорацетальдегида (50 мл) при перемешивании дл разделени его на два сло .Хлорацеталь- денид-гидратный слой (верхний слой) отдел ют и разбавл ют хлороформом (100 мл) смешивают с сульфатом магни (20 г), нагревают до кипени с обратным холодильником в течение 5 мин и фильтруют. Растворитель и воду удал ют азеотропно (температура кипени 56-64°С) и остаток перегон ют , получа безводный хлор- ацетальденид, температура кипени 70 82 с/760 мм рт.ст.Calcium chloride is added to a cooled solution of 50% aqueous chloroacetaldehyde (50 ml) with stirring to separate it into two layers. The chloroacetalide-hydride layer (upper layer) is separated and diluted with chloroform (100 ml) and mixed with sulfate magnesium (20 g), heated to reflux for 5 minutes and filtered. The solvent and water are removed azeotropically (boiling point 56-64 ° C) and the residue is distilled to give anhydrous chloroacetaldenide, boiling point 70 82 s / 760 mm Hg.
ИК-спектр : иакс (пленка) 1720смIR spectrum: iax (film) 1720cm
--
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US59794184A | 1984-04-09 | 1984-04-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
SU1436882A3 true SU1436882A3 (en) | 1988-11-07 |
Family
ID=24393575
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU864020682A SU1436882A3 (en) | 1984-04-09 | 1986-02-06 | Method of producing diphenylmethyl ether of 7-benzylidene-amino-3-(3-chloro-1-propen-1-yl) - cephem-4-carboxylic acid |
SU864023036A SU1367858A3 (en) | 1984-04-09 | 1986-02-06 | Method of producing cephalosporin derivatives |
SU864019975A SU1487814A3 (en) | 1984-04-09 | 1986-02-06 | Method of producing 7-amino-3-/3-(4-carbamoyl-1-pyridino)-1-propene-1-yl/-3-cephem-4-carboxylate |
SU864018257A SU1375140A3 (en) | 1984-04-09 | 1986-02-06 | Method of producing derivatives of cephalosporin or additive salts thereof with hydrogen halide acids |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU864023036A SU1367858A3 (en) | 1984-04-09 | 1986-02-06 | Method of producing cephalosporin derivatives |
SU864019975A SU1487814A3 (en) | 1984-04-09 | 1986-02-06 | Method of producing 7-amino-3-/3-(4-carbamoyl-1-pyridino)-1-propene-1-yl/-3-cephem-4-carboxylate |
SU864018257A SU1375140A3 (en) | 1984-04-09 | 1986-02-06 | Method of producing derivatives of cephalosporin or additive salts thereof with hydrogen halide acids |
Country Status (31)
Country | Link |
---|---|
JP (4) | JPS615084A (en) |
KR (1) | KR870002166B1 (en) |
AR (1) | AR244694A1 (en) |
AT (1) | AT388735B (en) |
AU (2) | AU580990B2 (en) |
BE (1) | BE902148A (en) |
CA (3) | CA1276929C (en) |
CH (1) | CH669197A5 (en) |
DD (3) | DD249024A5 (en) |
DE (1) | DE3512225A1 (en) |
DK (1) | DK155985A (en) |
ES (4) | ES8607318A1 (en) |
FI (1) | FI84830C (en) |
FR (1) | FR2563832B1 (en) |
GB (3) | GB2157293B (en) |
GR (1) | GR850883B (en) |
HU (2) | HU193750B (en) |
IE (2) | IE58408B1 (en) |
IL (1) | IL74826A (en) |
IT (1) | IT1190353B (en) |
LU (1) | LU85840A1 (en) |
MY (1) | MY101940A (en) |
NL (1) | NL192925C (en) |
NZ (1) | NZ211659A (en) |
OA (1) | OA07985A (en) |
PT (1) | PT80246B (en) |
RU (1) | RU2056425C1 (en) |
SE (4) | SE466205B (en) |
SU (4) | SU1436882A3 (en) |
YU (2) | YU46151B (en) |
ZA (1) | ZA852236B (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61145186A (en) * | 1984-12-20 | 1986-07-02 | Meiji Seika Kaisha Ltd | Novel cephem compound and preparation thereof |
US4708955A (en) * | 1985-06-24 | 1987-11-24 | Bristol-Myers Company | 3-(substituted)propenyl-7-aminothiazol-ylcephalosporanic acids and esters thereof |
ATE114657T1 (en) * | 1985-12-26 | 1994-12-15 | Eisai Co Ltd | CEPHALOSPORIN COMPOUNDS. |
AU614723B2 (en) * | 1986-10-13 | 1991-09-12 | Eisai Co. Ltd. | 3-propenylcephem derivative |
IL84128A (en) * | 1986-10-13 | 1992-12-01 | Eisai Co Ltd | 3-propenylcephem derivatives, their preparation and pharmaceutical compositions containing them |
JPH085897B2 (en) * | 1986-11-06 | 1996-01-24 | エーザイ株式会社 | 3-propenyl cephem derivative |
FR2622585B1 (en) * | 1987-11-03 | 1991-04-19 | Roussel Uclaf | NOVEL CEPHALOSPORINS COMPRISING IN POSITION 3 A SUBSTITUTED VINYL RADICAL, THEIR PREPARATION PROCESS, THEIR APPLICATION AS MEDICAMENTS, THE COMPOSITIONS CONTAINING THEM AND THE NEW INTERMEDIATES OBTAINED |
JPH0699449B2 (en) * | 1988-03-16 | 1994-12-07 | エーザイ株式会社 | Synthetic intermediate of cephem derivative |
ATE212027T1 (en) * | 1988-03-16 | 2002-02-15 | Eisai Co Ltd | CEPHEM DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF |
FR2655042B1 (en) * | 1989-11-29 | 1994-01-21 | Adir Cie | NOVEL SUBSTITUTED BENZOTHIAZOLINONES, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
FR2663332B1 (en) * | 1990-06-15 | 1997-11-07 | Roussel Uclaf | NOVEL CEPHALOSPORINS COMPRISING IN POSITION 3 A RADICAL PROPENYL SUBSTITUTED BY A QUATERNARY AMMONIUM, THEIR PREPARATION PROCESS, THEIR APPLICATION AS MEDICAMENTS, THE COMPOSITIONS CONTAINING THEM AND THE NEW INTERMEDIATES OBTAINED. |
US5126336A (en) * | 1990-08-23 | 1992-06-30 | Bristol-Myers Squibb Company | Antibiotic c-3 catechol-substituted cephalosporin compounds, compositions and method of use thereof |
AT396108B (en) * | 1991-08-21 | 1993-06-25 | Biochemie Gmbh | NEW PROCESS AND NEW INTERMEDIATE PRODUCTS FOR THE PRODUCTION OF 7-AMINOCEPHALOSPORANIC ACID DERIVATIVES |
JPH0741484A (en) * | 1993-07-29 | 1995-02-10 | Katayama Seiyakushiyo:Kk | Cephem compound and antimicrobial agent |
EP0723966A4 (en) * | 1994-08-16 | 1997-01-29 | Meiji Seika Co | Novel cephem derivative |
TR200003807T2 (en) | 1998-06-22 | 2001-06-21 | Basilea Pharmaceutica Ag | Propenyl cephalosporin derivatives |
WO2005026176A1 (en) | 2003-09-09 | 2005-03-24 | Nippon Chemical Industrial Co.,Ltd. | Process for producing 3-chloromethyl-3-cephem derivative |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1342241A (en) * | 1970-01-23 | 1974-01-03 | Glaxo Lab Ltd | Cephalosporin compounds |
US4390534A (en) * | 1978-12-29 | 1983-06-28 | Fujisawa Pharmaceutical Co., Ltd. | Cephem and cepham compounds |
EP0025017A1 (en) * | 1979-08-28 | 1981-03-11 | Ciba-Geigy Ag | Polyazathia compounds, process for their preparation, pharmaceutical preparations containing such compounds and use of the latter |
US4409214A (en) * | 1979-11-19 | 1983-10-11 | Fujisawa Pharmaceutical, Co., Ltd. | 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof |
GR75644B (en) * | 1980-06-18 | 1984-08-02 | Fujisawa Pharmaceutical Co | |
GR78245B (en) * | 1980-09-12 | 1984-09-26 | Ciba Geigy Ag | |
US4521413A (en) * | 1981-09-14 | 1985-06-04 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
US4486586A (en) * | 1983-02-10 | 1984-12-04 | Bristol-Myers Company | Cephalosporin derivatives |
-
1985
- 1985-02-14 CA CA000474260A patent/CA1276929C/en not_active Expired - Lifetime
- 1985-03-25 ZA ZA852236A patent/ZA852236B/en unknown
- 1985-04-02 AR AR85299945A patent/AR244694A1/en active
- 1985-04-02 NZ NZ211659A patent/NZ211659A/en unknown
- 1985-04-03 DD DD85287524A patent/DD249024A5/en unknown
- 1985-04-03 DE DE19853512225 patent/DE3512225A1/en active Granted
- 1985-04-03 DK DK155985A patent/DK155985A/en not_active Application Discontinuation
- 1985-04-03 SE SE8501680A patent/SE466205B/en not_active IP Right Cessation
- 1985-04-03 DD DD85274832A patent/DD236735A5/en unknown
- 1985-04-04 NL NL8501002A patent/NL192925C/en not_active IP Right Cessation
- 1985-04-04 OA OA58561A patent/OA07985A/en unknown
- 1985-04-04 AU AU40862/85A patent/AU580990B2/en not_active Expired
- 1985-04-04 CH CH1498/85A patent/CH669197A5/en not_active IP Right Cessation
- 1985-04-04 FI FI851379A patent/FI84830C/en not_active IP Right Cessation
- 1985-04-04 IE IE86685A patent/IE58408B1/en not_active IP Right Cessation
- 1985-04-04 GB GB08508846A patent/GB2157293B/en not_active Expired
- 1985-04-04 PT PT80246A patent/PT80246B/en unknown
- 1985-04-05 AT AT0103985A patent/AT388735B/en not_active IP Right Cessation
- 1985-04-05 LU LU85840A patent/LU85840A1/en unknown
- 1985-04-05 FR FR8505281A patent/FR2563832B1/en not_active Expired
- 1985-04-05 IL IL74826A patent/IL74826A/en not_active IP Right Cessation
- 1985-04-05 IT IT20267/85A patent/IT1190353B/en active
- 1985-04-08 GR GR850883A patent/GR850883B/el not_active IP Right Cessation
- 1985-04-08 RU SU853878102A patent/RU2056425C1/en active
- 1985-04-08 ES ES542013A patent/ES8607318A1/en not_active Expired
- 1985-04-09 JP JP60075233A patent/JPS615084A/en active Granted
- 1985-04-09 HU HU851299A patent/HU193750B/en unknown
- 1985-04-09 KR KR1019850002383A patent/KR870002166B1/en not_active IP Right Cessation
- 1985-04-09 BE BE0/214810A patent/BE902148A/en not_active IP Right Cessation
- 1985-04-09 HU HU87151A patent/HU204277B/en unknown
- 1985-04-09 YU YU60085A patent/YU46151B/en unknown
- 1985-11-12 JP JP60252140A patent/JPS61143387A/en active Granted
- 1985-11-12 JP JP60252138A patent/JPS61143390A/en active Granted
- 1985-11-12 JP JP60252139A patent/JPS61143391A/en active Granted
-
1986
- 1986-01-31 ES ES551551A patent/ES8706694A1/en not_active Expired
- 1986-01-31 ES ES551550A patent/ES8706155A1/en not_active Expired
- 1986-02-06 SU SU864020682A patent/SU1436882A3/en active
- 1986-02-06 SU SU864023036A patent/SU1367858A3/en active
- 1986-02-06 SU SU864019975A patent/SU1487814A3/en active
- 1986-02-06 SU SU864018257A patent/SU1375140A3/en active
- 1986-03-03 DD DD86287525A patent/DD251752A5/en unknown
- 1986-09-10 ES ES557060A patent/ES8800949A1/en not_active Expired
-
1987
- 1987-06-25 YU YU118987A patent/YU46213B/en unknown
- 1987-09-10 GB GB08721346A patent/GB2194789B/en not_active Expired
- 1987-09-10 GB GB08721347A patent/GB2194790B/en not_active Expired
- 1987-10-01 MY MYPI87002761A patent/MY101940A/en unknown
-
1988
- 1988-11-11 AU AU25041/88A patent/AU610278B2/en not_active Expired
-
1989
- 1989-04-04 IE IE121089A patent/IE58403B1/en not_active IP Right Cessation
- 1989-04-06 SE SE8901226A patent/SE470260B/en not_active IP Right Cessation
- 1989-04-06 SE SE8901225A patent/SE505256C2/en not_active IP Right Cessation
- 1989-04-06 SE SE8901224A patent/SE470259B/en not_active IP Right Cessation
-
1991
- 1991-08-12 CA CA000616143A patent/CA1340638C/en not_active Expired - Fee Related
- 1991-08-21 CA CA000616144A patent/CA1340672C/en not_active Expired - Fee Related
Non-Patent Citations (1)
Title |
---|
Патент СССР № 1181548А, кл. С 07 D 501/18, 1979. Патент US № 4065620, кл. 544-16, опублик.1977. Патент US № 4110534, кл. 544-16, опублик, 1978. * |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SU1436882A3 (en) | Method of producing diphenylmethyl ether of 7-benzylidene-amino-3-(3-chloro-1-propen-1-yl) - cephem-4-carboxylic acid | |
SE434949B (en) | PROCEDURE FOR PREPARING 7BETA-ACYLAMINO-7ALFA-ALCOXICEPHALOSPORINES OR 6BETA-ACYLAMINO-6ALFA-ALCOXIPENICILLINES | |
DK163584B (en) | 7-AMINO-3-PROPENYLECEPHALOSPORIC ACID DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF | |
US4139618A (en) | Cephalosporin type antibacterials | |
US4699979A (en) | 7-amino-3-propenylcephalosporanic acid and esters thereof | |
GB2101986A (en) | Thiazolinoazetidinone derivatives | |
US4094978A (en) | 3-propenyl derivatives of cephalosporin, compositions and their use | |
US5919939A (en) | Preparation of cephem and isooxacephem derivatives | |
FI75165B (en) | FOERBAETTRAT FOERFARANDE FOER FRAMSTAELLNING AV PENICILLANSYRAKLORMETYLESTRAR. | |
US3998817A (en) | Process for producing cephalosporanic acid derivatives | |
KR870002181B1 (en) | Process for preparing cephalosporins | |
EP0055933B1 (en) | 6-(2-aryl-2-(1,1-dioxopenicillanoyloxy-methoxycarbonyl)acetamido) penicillanic acids | |
US4051131A (en) | Intermediates for preparing cephalosporins | |
EP0117872B1 (en) | Process for preparing cephalosporin compounds | |
SU797579A3 (en) | Method of preparing acid amides or their salts with alkaline metals or trialkylamines | |
SU685157A3 (en) | Method of obtaining 7-amino-3-/(1-carboxymethylterazol-5-yl)/-3-cephem-4-carboxylic acid | |
US4171303A (en) | Process for the preparation of reactive penicillanic acid and cephalosporanic acid derivatives | |
US3965098A (en) | Intermediates for preparing cephalosporins and methods of production | |
US4210750A (en) | Process for the preparation of 3-carbamoyl cephalosporins using isocyanates | |
US4959495A (en) | Process for the preparation of intermediates used to produce aminothiazoloximino cephalosporins | |
US3799922A (en) | 4-substituted 3-cephem compounds | |
US3971780A (en) | Thio-β-lactam cephalosporins | |
EP0049309B1 (en) | Cephem derivatives, process for producing thereof, and antibacterial agents comprising said compounds | |
US4659812A (en) | Cephalosporin intermediates | |
EP0096496B1 (en) | Preparation of penicillin and cephalosporin compounds and novel intermediates useful therein |